1-151171464-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_013353.3(TMOD4):āc.695T>Cā(p.Val232Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000173 in 1,614,076 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_013353.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMOD4 | NM_013353.3 | c.695T>C | p.Val232Ala | missense_variant | 7/10 | ENST00000295314.9 | NP_037485.2 | |
TMOD4 | XM_011509449.2 | c.695T>C | p.Val232Ala | missense_variant | 7/10 | XP_011507751.1 | ||
TMOD4 | XM_047418672.1 | c.695T>C | p.Val232Ala | missense_variant | 6/9 | XP_047274628.1 | ||
TMOD4 | XM_017001090.3 | c.618+169T>C | intron_variant | XP_016856579.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251464Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135904
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461894Hom.: 1 Cov.: 33 AF XY: 0.0000206 AC XY: 15AN XY: 727248
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 28, 2024 | The c.695T>C (p.V232A) alteration is located in exon 7 (coding exon 6) of the TMOD4 gene. This alteration results from a T to C substitution at nucleotide position 695, causing the valine (V) at amino acid position 232 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at